Immunology

Reviewing new challenges and opportunities for hepatitis B cures

Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading ...

Diseases, Conditions, Syndromes

People with a hepatitis C cure still face substantial risk of death

Individuals who have been cured of hepatitis C infection still face a substantially greater risk of death compared with the general population—between 3 and 14 times higher depending on liver disease stage, finds the largest ...

Diseases, Conditions, Syndromes

NIH updates Hepatitis B Strategic Research Plan

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, ...

Medications

Specialty pharmacists help reduce MS relapse risk

Relapsing multiple sclerosis (RMS) is the most common form of multiple sclerosis. Since there is no cure, patients are maintained on disease-modifying therapy (DMT) to help slow disease progression, reduce disease relapses, ...

Medical research

Why most hangover cures don't work but a few might help

Most of us know that horrible feeling of tiredness, headache, sweating, nausea and sensitivity to light—the dreaded hangover. For decades researchers have been exploring potential cures for hangovers induced by alcohol.

Diseases, Conditions, Syndromes

S.Africa trial shows promise for drug-resistant TB regimen

Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.

page 2 from 7